08/28/2025 07:00
Europa Worldwide Group Enhances Carbon Management and Reporting With Blue Yonder

The global regulatory landscape, particularly in the U.K. and European Union, acts as a powerful catalyst for change, urging companies to embrace sustainable practices that extend beyond basic compliance. Logistics service providers (LSPs) are witnessing an increased demand from their customers to actively monitor emissions and ensure adherence to both current and forthcoming regulations. That’s why Europa Worldwide Group, a leading LSP with a global presence, has adopted Blue Yonder’s Logistic...

09/02/2025 10:10
Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield to Acquire Air Lease Corporation in 100% Cash Transaction

Sumitomo Corporation, SMBC Aviation Capital, Apollo managed funds (“Apollo”) and Brookfield, today announced that they have reached a definitive agreement to acquire Air Lease Corporation (“Air Lease”), a leading aircraft lessor founded by Steven F. Udvar-Házy and John L. Plueger with a portfolio primarily comprised of new technology aircraft. Upon closing, Air Lease will be renamed Sumisho Air Lease, a newly established entity. Apollo and Brookfield have agreed to provide capital to support th...

07/21/2025 07:55
Omdia Forecasts Large-Area Display Shipments to Grow 2.9% YoY in 2025 Despite Economic Uncertainty

According to the latest analysis from Omdia’s Large-area display market tracker – 2Q25 with 1Q25 results, large-area display (above 9-inch) unit shipments are forecast to increase by 2.9% year-over-year (YoY) in 2025. While growth in 2025 is expected to be smaller than that of 2024, this increase comes in the face of global economic uncertainty and US tariff concerns. Notably, TV and monitor applications are projected to experience negative growth in 2025. Chinese panel makers, who are expe...

09/02/2025 10:30
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of results from an open-label Phase 2 study evaluating the safety and tolerability of a single-dose of 25 mg of investigational COMP360 synthetic psilocybin treatment in 22 patients with post-traumatic stress disorder (PTSD). The Phase 2 study findings, previously disclosed in May 2024, show that COMP360 was well tol...

09/02/2025 11:00
IFF Tackles Top Challenges in Baking at IBIE 2025

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, health and biosciences, will showcase how it is helping the global baking industry overcome some of its toughest challenges at the International Baking Industry Exposition (IBIE) 2025 in Las Vegas. From soaring cocoa and egg prices to stricter regulations and rising demand for healthier baked goods, IFF is stepping forward with bold, science-led solutions designed to keep industrial bakers ahead of the curve. This press...